Literature DB >> 14985917

MDMA: fact and fallacy, and the need to increase knowledge in both the scientific and popular press.

A Richard Green1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14985917     DOI： 10.1007/s00213-004-1820-z

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  10 in total

1.  Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine ("ecstasy") and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice.

Authors:  William E Fantegrossi; Tomek Godlewski; Rachel L Karabenick; Jermaine M Stephens; Thomas Ullrich; Kenner C Rice; James H Woods
Journal:  Psychopharmacology (Berl)       Date:  2003-02-01       Impact factor: 4.530

Review 2.  Molecular genetics of the debrisoquin-sparteine polymorphism.

Authors:  F J Gonzalez; U A Meyer
Journal:  Clin Pharmacol Ther       Date:  1991-09       Impact factor: 6.875

3.  The action of some amines related to adrenaline. Cyclohexylalkylamines.

Authors:  J A Gunn; M R Gurd
Journal:  J Physiol       Date:  1940-02-14       Impact factor: 5.182

4.  Retraction.

Authors:  George A Ricaurte; Jie Yuan; George Hatzidimitriou; Branden J Cord; Una D McCann
Journal:  Science       Date:  2003-09-12       Impact factor: 47.728

5.  Non-linear pharmacokinetics of MDMA ('ecstasy') in humans.

Authors:  R de la Torre; M Farré; J Ortuño; M Mas; R Brenneisen; P N Roset; J Segura; J Camí
Journal:  Br J Clin Pharmacol       Date:  2000-02       Impact factor: 4.335

6.  Repeated doses administration of MDMA in humans: pharmacological effects and pharmacokinetics.

Authors:  M Farré; R de la Torre; B O Mathúna; P N Roset; A M Peiró; M Torrens; J Ortuño; M Pujadas; J Camí
Journal:  Psychopharmacology (Berl)       Date:  2004-04-08       Impact factor: 4.530

Review 7.  The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").

Authors:  A Richard Green; Annis O Mechan; J Martin Elliott; Esther O'Shea; M Isabel Colado
Journal:  Pharmacol Rev       Date:  2003-07-17       Impact factor: 25.468

8.  Severe dopaminergic neurotoxicity in primates after a common recreational dose regimen of MDMA ("ecstasy").

Authors:  George A Ricaurte; Jie Yuan; George Hatzidimitriou; Branden J Cord; Una D McCann
Journal:  Science       Date:  2002-09-27       Impact factor: 47.728

9.  Small changes in ambient temperature cause large changes in 3,4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat.

Authors:  J E Malberg; L S Seiden
Journal:  J Neurosci       Date:  1998-07-01       Impact factor: 6.167

10.  The demethylenation of methylenedioxymethamphetamine ("ecstasy") by debrisoquine hydroxylase (CYP2D6).

Authors:  G T Tucker; M S Lennard; S W Ellis; H F Woods; A K Cho; L Y Lin; A Hiratsuka; D A Schmitz; T Y Chu
Journal:  Biochem Pharmacol       Date:  1994-03-29       Impact factor: 5.858
  10 in total
  5 in total

1.  3,4-Methylenedioxymethamphetamine in adult rats produces deficits in path integration and spatial reference memory.

Authors:  Jessica A Able; Gary A Gudelsky; Charles V Vorhees; Michael T Williams
Journal:  Biol Psychiatry       Date:  2005-12-01       Impact factor: 13.382

Review 2.  The role of monoamines in the changes in body temperature induced by 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its derivatives.

Authors:  J R Docherty; A R Green
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

Review 3.  Lost in translation: preclinical studies on 3,4-methylenedioxymethamphetamine provide information on mechanisms of action, but do not allow accurate prediction of adverse events in humans.

Authors:  A R Green; M V King; S E Shortall; K C F Fone
Journal:  Br J Pharmacol       Date:  2012-07       Impact factor: 8.739

Review 4.  Neuroimaging research in human MDMA users: a review.

Authors:  Ronald L Cowan
Journal:  Psychopharmacology (Berl)       Date:  2006-07-18       Impact factor: 4.530

5.  N-acetylaspartate (NAA) correlates inversely with cannabis use in a frontal language processing region of neocortex in MDMA (Ecstasy) polydrug users: a 3 T magnetic resonance spectroscopy study.

Authors:  Ronald L Cowan; James M Joers; Mary S Dietrich
Journal:  Pharmacol Biochem Behav       Date:  2008-11-13       Impact factor: 3.533
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.